Stocks and Investing Stocks and Investing
Mon, October 7, 2019
Fri, October 4, 2019
Thu, October 3, 2019

Andrew Fein Initiated (BPMC) at Strong Buy and Held Target at $100 on, Oct 3rd, 2019


Published on 2024-10-26 16:38:38 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $100 on, Oct 3rd, 2019.

Andrew has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Initiated at Hold and Held Target at $85 on, Thursday, August 29th, 2019


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Dane Leone of "Raymond James" Upgraded from Hold to Buy on, Thursday, September 12th, 2019
  • Joel Beatty of "Baird" Initiated at Buy and Held Target at $120 on, Friday, July 19th, 2019
  • Konstantinos Aprilakis of "Deutsche Bank" Initiated at Strong Buy and Held Target at $110 on, Thursday, July 18th, 2019

Contributing Sources